X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2128) 2128
exanthema - chemically induced (1847) 1847
science & technology (1387) 1387
life sciences & biomedicine (1381) 1381
female (1265) 1265
male (1187) 1187
middle aged (923) 923
adult (864) 864
aged (666) 666
drug eruptions - etiology (448) 448
dermatology (368) 368
exanthema (312) 312
treatment outcome (303) 303
oncology (290) 290
adolescent (238) 238
exanthema - pathology (232) 232
antineoplastic agents - adverse effects (229) 229
aged, 80 and over (225) 225
abridged index medicus (218) 218
exanthema - diagnosis (214) 214
child (200) 200
rash (199) 199
pharmacology & pharmacy (192) 192
immunology (178) 178
retrospective studies (167) 167
diagnosis, differential (163) 163
allergy (158) 158
skin (153) 153
general & internal medicine (150) 150
care and treatment (145) 145
medicine, general & internal (145) 145
drug eruptions - pathology (140) 140
anti-bacterial agents - adverse effects (135) 135
drug hypersensitivity - etiology (135) 135
fever - chemically induced (135) 135
antineoplastic agents - therapeutic use (133) 133
acute disease (132) 132
exanthema - drug therapy (131) 131
drug eruptions - diagnosis (128) 128
young adult (126) 126
risk factors (125) 125
receptor, epidermal growth factor - antagonists & inhibitors (124) 124
child, preschool (118) 118
quinazolines - adverse effects (118) 118
anticonvulsants - adverse effects (116) 116
lung neoplasms - drug therapy (116) 116
antibodies, monoclonal - adverse effects (113) 113
diarrhea - chemically induced (113) 113
time factors (109) 109
carcinoma, non-small-cell lung - drug therapy (107) 107
infectious diseases (106) 106
cancer (105) 105
follow-up studies (102) 102
skin - pathology (101) 101
skin diseases, vesiculobullous - chemically induced (99) 99
antineoplastic combined chemotherapy protocols - therapeutic use (98) 98
dose-response relationship, drug (98) 98
protein kinase inhibitors - adverse effects (98) 98
complications and side effects (96) 96
administration, oral (95) 95
drug therapy (95) 95
eosinophilia - chemically induced (94) 94
syndrome (93) 93
antineoplastic combined chemotherapy protocols - adverse effects (90) 90
hiv infections - drug therapy (90) 90
pruritus - chemically induced (90) 90
drug therapy, combination (89) 89
medicine & public health (86) 86
cetuximab (85) 85
exanthema - epidemiology (84) 84
research (83) 83
side effects (83) 83
drug hypersensitivity - diagnosis (79) 79
infant (77) 77
drug hypersensitivity (74) 74
skin tests (74) 74
erlotinib hydrochloride (73) 73
nausea - chemically induced (73) 73
neoplasms - drug therapy (71) 71
animals (70) 70
pediatrics (70) 70
antibodies, monoclonal, humanized (69) 69
exanthema - immunology (69) 69
quinazolines - therapeutic use (69) 69
toxicity (69) 69
patch tests (68) 68
drug administration schedule (67) 67
urticaria - chemically induced (67) 67
health aspects (66) 66
incidence (66) 66
analysis (65) 65
neurosciences & neurology (65) 65
patients (65) 65
disease-free survival (64) 64
chemotherapy (63) 63
severity of illness index (63) 63
anti-hiv agents - adverse effects (62) 62
clinical neurology (62) 62
biopsy (61) 61
hematology (61) 61
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1847) 1847
German (151) 151
French (53) 53
Chinese (45) 45
Spanish (30) 30
Japanese (23) 23
Dutch (11) 11
Norwegian (10) 10
Danish (9) 9
Portuguese (5) 5
Swedish (4) 4
Czech (3) 3
Hungarian (3) 3
Italian (3) 3
Serbian (3) 3
Croatian (2) 2
Finnish (1) 1
Polish (1) 1
Russian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


CA: a cancer journal for clinicians, ISSN 0007-9235, 07/2013, Volume 63, Issue 4, pp. 249 - 279
Answer questions and earn CME/CNE Advances in genomics and molecular biology have identified aberrant proteins in cancer cells that are attractive targets for... 
toxicity | kinase inhibitors | therapeutic index | targeted agents | mechanism‐based toxicity | immunotherapeutic agents | off‐target toxicity | mechanism-based toxicity | off-target toxicity | Life Sciences & Biomedicine | Oncology | Science & Technology | Mood Disorders - chemically induced | Drug Eruptions - etiology | Peripheral Nervous System Diseases - chemically induced | Bone Marrow Diseases - chemically induced | Cachexia - chemically induced | Endocrine System Diseases - chemically induced | Pleural Effusion - chemically induced | Humans | Drug Eruptions - therapy | Immune System Diseases - chemically induced | Lung Diseases, Interstitial - chemically induced | Thrombocytopenia - chemically induced | Diarrhea - chemically induced | Neoplasms - drug therapy | Antineoplastic Agents - adverse effects | Exanthema - chemically induced | Hyperbilirubinemia - chemically induced | Venous Thromboembolism - chemically induced | Vision Disorders - chemically induced | Hemorrhage - chemically induced | Heart Diseases - chemically induced | Hyperlipidemias - chemically induced | Magnesium - blood | Antimitotic agents | Drugs | Prevention | Complications and side effects | Drug targeting | Antineoplastic agents | Health aspects | Risk factors | Proteins | Side effects | Genomics | Cytotoxicity | Molecular biology | Cancer therapies | Cells | Index Medicus | Abridged Index Medicus
Journal Article
British journal of haematology, ISSN 0007-1048, 03/2018, Volume 180, Issue 5, pp. 666 - 679
Journal Article
The Medical clinics of North America, ISSN 0025-7125, 07/2010, Volume 94, Issue 4, pp. 711 - 725
Journal Article